Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the unique challenges faced by transgender patients with end-stage renal disease during the transplant process and outlines current management recommendations, but it reports no new clinical results.

This review discusses the preliminary results of using rotational thrombectomy for acute dialysis-access graft occlusion in the upper extremity, reporting no new clinical outcomes.

This study concluded that while remote interventions using digital health technology can enhance health-related outcomes, medication adherence, and economic status in kidney transplant recipients, their effect on tacrolimus concentration is not clearly understood.

This review discusses various skin conditions linked with chronic kidney disease and highlights effective treatments but does not provide new clinical results.

This study found that patients on maintenance hemodialysis commonly experience cutaneous symptoms, with pigmentation and nail disorders being the most prevalent.

This review found that Tolvaptan is the only drug shown to slow the progression of autosomal dominant polycystic kidney disease, but it does not affect mortality or kidney failure outcomes.

This study suggests that 5-alpha reductase inhibitors may reduce invasive cancer features and improve survival in men undergoing radical cystectomy for high-grade urothelial carcinoma, although further research is needed to confirm these findings.

This study found that feminizing hormone therapy increased GFR in transgender individuals assigned male at birth, suggesting an effect of sex hormones on kidney hemodynamics, while masculinizing therapy showed a slight, nonsignificant decrease in GFR.

This study developed a kidney-specific knockout mouse model lacking the Flcn gene, which recapitulates human Birt-Hogg-Dubé kidney tumorigenesis and shows that mTOR pathway inhibition with rapamycin can suppress tumor growth.

This study reported that 83.1% of patients with end-stage renal disease on hemodialysis experienced skin conditions, with xerosis affecting 63.6%, pruritis 36.4%, and notable occurrences of nail and oral anomalies, indicating a need for targeted dermatological management to improve patients' quality of life.

This review discusses inflammatory and medication-related nephrocutaneous disease associations and emphasizes the importance of timely referral to nephrology for early management, but it reports no new clinical results.

This case report describes a 70-year-old kidney transplant recipient who developed a keratoacanthoma near an arteriovenous fistula after returning to hemodialysis and stopping immunosuppression.

In this study, researchers observed that all kidney transplant patients at a Mexico City hospital developed at least one type of skin condition, with infectious dermatoses being the most common. The authors recommend dermatological assessments before transplantation to manage dermatoses, potentially reducing related health risks.

This study observed that chronic kidney disease patients undergoing hemodialysis frequently experience dermatologic manifestations, with xerosis and white nail being the most common skin and nail changes noted in 74% and 56% of patients, respectively.

This study observed that nearly all kidney transplant patients experienced complications from immunosuppressive therapy, with excessive hair growth and increased blood sugar being the most common issues.

This abstract contains no research findings and pertains only to website navigation and policies.

This study found that patients with lupus nephritis experience a greater overall burden than those with systemic lupus erythematosus without nephritis, particularly impacting areas such as family planning, professional life, disease features, medication usage, and quality of life.

This study found that in a large cohort of chronic kidney disease patients, nonprogression or regression of the disease was more common than progression or kidney failure, especially with advancing age.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

This study found that while kidney transplant recipients generally reported good quality of life on immunosuppressive therapies, women experienced more distressing symptoms and lower satisfaction compared to men.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

This medical case report describes a 69-year-old man's diagnosis and management of ANCA-associated vasculitis leading to rapidly progressive glomerulonephritis, ultimately treated with glucocorticoids and rituximab.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

In this study, researchers found that retinoids might improve lupus nephritis resistant to conventional treatments, but the sample size was too small for significant results, and side effects were noted.

This article discusses the potential benefits and challenges of metatrials as a new clinical trial methodology during COVID-19 and reflects on its application in nephrology, but reports no new results.

This study found that men prescribed Finasteride had a lower incidence of bladder cancer compared to those not on the medication, but this protective effect was observed only in Caucasians and Hispanics.

This case study provides an exemplar of a 75-year-old man with metastatic renal cell carcinoma, outlining his medical history, recent imaging findings, and treatment decisions; it reports no clinical results.

This study found that enalapril treatment reduced hematocrit levels in posttransplant erythrocytosis patients and increased transferrin saturation index and ferritin levels in those with iron deficiency among long-term renal transplant recipients.